These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7711426)
1. Limited trypsin proteolysis renders carnitine palmitoyltransferase insensitive to inhibition by malonyl-CoA in patients with muscle carnitine palmitoyltransferase deficiency. Zierz S Clin Investig; 1994 Dec; 72(12):957-60. PubMed ID: 7711426 [TBL] [Abstract][Full Text] [Related]
2. Carnitine acyltransferases in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency. Neumann-Schmidt S; Zierz S Neuromuscul Disord; 1991; 1(4):253-60. PubMed ID: 1822803 [TBL] [Abstract][Full Text] [Related]
3. Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Zierz S; Engel AG Eur J Biochem; 1985 May; 149(1):207-14. PubMed ID: 3996401 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of carnitine palmitoyltransferase in normal human skeletal muscle and in muscle of patients with carnitine palmitoyltransferase deficiency by long- and short-chain acylcarnitine and acyl-coenzyme A. Zierz S; Neumann-Schmidt S; Jerusalem F Clin Investig; 1993 Oct; 71(10):763-9. PubMed ID: 8305830 [TBL] [Abstract][Full Text] [Related]
5. Different sites of inhibition of carnitine palmitoyltransferase by malonyl-CoA, and by acetyl-CoA and CoA, in human skeletal muscle. Zierz S; Engel AG Biochem J; 1987 Jul; 245(1):205-9. PubMed ID: 3663146 [TBL] [Abstract][Full Text] [Related]
7. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features. Lehmann D; Motlagh L; Robaa D; Zierz S Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946 [TBL] [Abstract][Full Text] [Related]
8. Biochemical evidence for heterozygosity in muscular carnitine palmitoyltransferase deficiency. Zierz S; Mundegar RR; Jerusalem F Clin Investig; 1993 Dec; 72(1):77-83. PubMed ID: 8136624 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the malonyl-CoA-sensitive carnitine palmitoyltransferase (CPTo) of a rat heart mitochondrial particle. Evidence that the catalytic unit is CPTi. Kerner J; Zaluzec E; Gage D; Bieber LL J Biol Chem; 1994 Mar; 269(11):8209-19. PubMed ID: 8132545 [TBL] [Abstract][Full Text] [Related]
10. Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach. Joshi PR; Zierz S Molecules; 2020 Apr; 25(8):. PubMed ID: 32295037 [TBL] [Abstract][Full Text] [Related]
11. Evidence of a malonyl-CoA-insensitive carnitine palmitoyltransferase I activity in red skeletal muscle. Kim JY; Koves TR; Yu GS; Gulick T; Cortright RN; Dohm GL; Muoio DM Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1014-22. PubMed ID: 11934665 [TBL] [Abstract][Full Text] [Related]
12. Different sensitivities of CPT I and CPT II for inhibition by l-aminocarnitine in human skeletal muscle. Traufeller K; Gellerich FN; Zierz S Biochim Biophys Acta; 2004 Feb; 1608(2-3):149-54. PubMed ID: 14871492 [TBL] [Abstract][Full Text] [Related]
13. Malony-CoA inhibits the S113L variant of carnitine-palmitoyltransferase II. Motlagh L; Golbik R; Sippl W; Zierz S Biochim Biophys Acta; 2016 Jan; 1861(1):34-40. PubMed ID: 26477380 [TBL] [Abstract][Full Text] [Related]
14. Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation. Kashfi K; Mynatt RL; Cook GA Biochim Biophys Acta; 1994 May; 1212(2):245-52. PubMed ID: 8180250 [TBL] [Abstract][Full Text] [Related]
15. Malonyl-CoA inhibits proteolysis of carnitine palmitoyltransferase. Kashfi K; Cook GA Biochem Biophys Res Commun; 1991 Jul; 178(2):600-5. PubMed ID: 1859420 [TBL] [Abstract][Full Text] [Related]
16. Time-dependence of inhibition of carnitine palmitoyltransferase I by malonyl-CoA in mitochondria isolated from livers of fed or starved rats. Evidence for transition of the enzyme between states of low and high affinity for malonyl-CoA. Zammit VA Biochem J; 1984 Mar; 218(2):379-86. PubMed ID: 6712621 [TBL] [Abstract][Full Text] [Related]
17. A proportion of rat liver mitochondrial carnitine palmitoyltransferase can be made activatable by malonyl-CoA. Ghadiminejad I; Saggerson D Biochim Biophys Acta; 1991 Oct; 1085(3):377-80. PubMed ID: 1911872 [TBL] [Abstract][Full Text] [Related]
18. Re-evaluation of the interaction of malonyl-CoA with the rat liver mitochondrial carnitine palmitoyltransferase system by using purified outer membranes. Kolodziej MP; Zammit VA Biochem J; 1990 Apr; 267(1):85-90. PubMed ID: 2327991 [TBL] [Abstract][Full Text] [Related]
19. Cholate extracts of mitochondrial outer membranes increase inhibition by malonyl-CoA of carnitine palmitoyltransferase-I by a mechanism involving phospholipids. Mynatt RL; Greenhaw JJ; Cook GA Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):761-7. PubMed ID: 8192665 [TBL] [Abstract][Full Text] [Related]
20. Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. Mills SE; Foster DW; McGarry JD Biochem J; 1983 Jul; 214(1):83-91. PubMed ID: 6615474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]